Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Classical hematology 1Breast 1

Conditions

Breast Neoplasms 61Neoplasm Metastasis 6Neoplasms 4Endometrial Neoplasms 4Colorectal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Triple Negative Breast Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Recurrence 2Ovarian Neoplasms 2Neuroblastoma 2Neoplasms by Site 2Melanoma 2Hereditary Sensory and Autonomic Neuropathies 2Glioma 2Glioblastoma 2Carcinoma, Ovarian Epithelial 2Breast Diseases 2Anatomic Stage II Breast Cancer AJCC v8 2Venous Thromboembolism 1Uterine Cervical Neoplasms 1Unilateral Breast Neoplasms 1Stomach Neoplasms 1Solid Tumors 1Sarcoma 1Rhabdomyosarcoma 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Meningioma 1

Interventions

apixaban 10Rivaroxaban 5Aspirin 4Enoxaparin 3abelacimab 2MAA868 2Heparin, Low-Molecular-Weight 2Dalteparin 2ribociclib 1palbociclib 1isoquercitrin 1enoxaparin sodium 1edoxaban 1abemaciclib 1Rosuvastatin Calcium 1N(4)-oleylcytosine arabinoside 1Educational Status 1Dabigatran 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Venous Thromboembolism × ribociclib × 1 year × Clear all
NCT07008508 2025-06-06

BRAVE-Cyclin

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Active not recruiting
300 enrolled
BreastClassical hematology

Breast Neoplasms, Cardiovascular Diseases, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡